Literature DB >> 11239762

Are alcohol intake and smoking associated with mycosis fungoides? A European multicentre case-control study.

M M Morales Suárez-Varela1, J Olsen, L Kaerlev, P Guénel, P Arveux, G Wingren, L Hardell, W Ahrens, A Stang, A Llopis-Gonzalez, F Merletti, F Guillén-Grima, P Johansen.   

Abstract

The incidence of mycosis fungoides (MF) is low, and the aetiology of the disease is unknown. The aim of this study was to investigate whether wine consumption protects against the disease and whether smoking constitutes a risk factor. This paper is part of the European Rare Cancers Study that tries to determine the risk factors for seven selective rare cancers, including mycosis fungoides, involved in the development of cancer. A multicentre case-control study was conducted in six European countries. Only incident cases with confirmed histology were included in the analysis which include a total of 76 cases of MF and 2899 controls. Wine intake had no protective effect; on the contrary the consumption of more than 24 g of alcohol per day was associated with a high risk of MF (odds ratio (OR)=3.02, 95% confidence interval (CI), 1.34-6.79), after adjusting for centre, country, age, sex and education. There was a dose-dependent increase in the risk of MF with increased smoking habits, albeit the observed trend was not statistically significant. A combined exposure to high tobacco and alcohol use yielded a significantly increased risk factor for MF (P=0.0073). Alcohol intake was associated with MF.

Entities:  

Mesh:

Year:  2001        PMID: 11239762     DOI: 10.1016/s0959-8049(00)00383-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

Review 1.  T-cell Lymphoma Epidemiology: the Known and Unknown.

Authors:  Anh Phan; Rachel Veldman; Mary Jo Lechowicz
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

2.  Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Briseis Aschebrook-Kilfoy; Pierluigi Cocco; Carlo La Vecchia; Ellen T Chang; Claire M Vajdic; Marshall E Kadin; John J Spinelli; Lindsay M Morton; Eleanor V Kane; Joshua N Sampson; Carol Kasten; Andrew L Feldman; Sophia S Wang; Yawei Zhang
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

Review 3.  Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-26       Impact factor: 10.047

4.  Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.

Authors:  Alexandra C Hristov; Trilokraj Tejasvi; Ryan A Wilcox
Journal:  Am J Hematol       Date:  2021-08-02       Impact factor: 13.265

5.  Colon cancer controls versus population controls in case-control studies of occupational risk factors.

Authors:  Linda Kaerlev; Elsebeth Lynge; Svend Sabroe; Jorn Olsen
Journal:  BMC Cancer       Date:  2004-04-22       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.